The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.Linvention concerne des inhibiteurs de S-nitrosoglutathione réductase (GSNOR), des compositions pharmaceutiques comprenant de tels inhibiteurs de GSNOR, et des procédés de fabrication et dutilisation de ceux-ci.